Key result
Higher red blood cell distribution width (RDW) was associated with more severe functional classes of chronic heart failure, suggesting its utility as a biomarker of disease severity.
Why the study?
Chronic heart failure carries a high mortality rate, making early identification of patients at risk of poor outcomes critical to optimize treatment.
Cross-Sectional (n=403)
No
Red blood cell distribution width (RDW) is significantly associated with the severity of chronic heart failure functional class, suggesting its potential as an accessible biomarker in routine clinical practice.
Answers are grounded in this paper and cite their sources.
RDW may indicate CHF severity in elderly patients; leaves open prospective validation before routine biomarker use.
Introduction. Chronic heart failure (CHF) is recognized as one of the most severe cardiovascular diseases with a high mortality rate. Early identification of patients at risk of poor outcomes is critical to optimize treatment. Aim: to conduct comparative analysis of laboratory markers, including the erythrocyte heterogeneity index (RDW) in CHF patients of different functional classes (f.cl.) according to ICD-10 codes. Materials and methods. A retrospective cross-sectional study with an analysis of the electronic laboratory register (JanuaryDecember 2016). 8056 patients who underwent a clinical blood test and added CRP parameters were included. The determination of the patient’s belonging to CHF wascarried out according to the ICD-10 code indicated in the direction for analysis. Identification of CHF patients by f.cl. (NYHA) was carried out according to the ICD-10 codes: code I25.2 (Postponed myocardial infarction) – 1 f. cl.; code I11.0 (Hypertensive disease with predominant heart damage with heart failure) – 2–3 f.cl .; code I50.0 (Congestive heart failure) – 4 f.cl. Results. The proportion of patients with diseases of the circulatory system (code I) was 33.4% (n = 2686), of which 403 CHF patients were selected for the study. Distribution by f.cl. according to the code MKB-10: 1 ph.cl. – 0.83% (n = 67); 2–3 f.c. – 3.84% (n = 309); 4 ph.cl. – 0.33% (n = 27). Significant intergroup differences were obtained between ph.cl. (according to Kruskal–Wallis) for indicators: hemoglobin (H = 9.741111, p = 0.0077), erythrocytes (H = 7.176770, p = 0.0276), RDW indicator (H = 34.78287, p = 0.0000). There were no statistically significant differences in leukocytes, platelets, ESR, CRP. Conclusions. The presence of anemia in groups of patients with CHF of different f.cl., which often accompanies the disease, has not been confirmed. But statistically significant differences were revealed depending on the severity of f.cl. CHF according to the level of hemoglobin, the number of erythrocytes, and highly significant - according to the RDW indicator. The latter allows us to discuss the role of the RDW index as a possible new laboratory biomarker of CHF severity available for routine clinical practice.
No takes yet. Share an insight, caveat, or question.
Gaisenok et al. (2021) conducted a cross-sectional in Chronic heart failure (n=403). Red blood cell distribution width (RDW) vs. Different functional classes of CHF was evaluated on RDW levels across different functional classes of CHF (H=34.78, p=<0.0001). Higher red blood cell distribution width (RDW) was associated with more severe functional classes of chronic heart failure, suggesting its utility as a biomarker of disease severity.
Synapse has enriched 10 related papers. Consider them for comparative context: